News
TBDO collaborates with DINA-ITC
CRG Entrepreneurship Week 2024
The CRG Entrepreneurship Week is an annual event that brings together budding entrepreneurs, industry leaders, and seasoned professionals to foster innovation and entrepreneurship. This year’s edition we will have talks by:
The sessions below are open to the CRG community only.
You can join the sessions by clicking on this link.
July 1, 2024
10:00 h
Miquel Vila-Perelló – CEO of SpliceBio
"The Scientist's Journey"
July 2, 2024
12:00 h
Marina Rigau – CEO of Mimark
"Meet the Entrepreneur"
July 3, 2024
12:00 h
Daniel Oliver – Partner at Capital Cell
"Meet the Investor"
July 4, 2024
11:00 h
Héctor Pérez- VP at Ability Pharma
"Into the Clinical Path"
CRG Entrepreneurship Week 2023
Once again, we celebrate the CRG Entrepreneurship Week, a time to meet and discuss with innovators and the entrepreneurship community, who dream big and inspire others to bring their ideas to life while driving socio-economic growth and welfare.
Targeting students, researchers, alumni, mentors, start-ups, industry, investors and other innovation partners.
The sessions below are open to the CRG community only.
You can join the sessions by clicking on this link.
April 24, 2023
10:30 h
Evan Floden, Seqera Labs
"The Scientist's Journey"
April 25, 2023
12:00 h
Joan Perelló, Sanifit
"Meet the Entrepreneur"
April 27, 2023
09:30 h
Malcolm Bain, Across Legal SLP
"Software Protection"
April 27, 2023
14:00 h
Gabor Heltovics, NLC Ventures
"Meet the Venture Builder"
TBDO Sessions Malcolm Bain
14/09/202212:00473.10TBDO SessionsMalcolm BainAcross LegalLicensing research software: options and challenges.Host: Sanz Molinero, Ana IsabelAbstract:Malcolm is an English solicitor and Spanish abogado. He has worked as an Information Technology and Intellectual Property lawyer over the last 20 years, with a specialisation in technology licensing, open source software and content, technology transfer and privacy.
In 2006, together with his partner Manuel Martínez, he founded his own firm “id-law partners” as a boutique specialized in IP and ICT. In May 2018, both incorporated this firm into Across Legal. In addition to his professional activity advising entrepreneurs, private companies, public administrations and open source projects, Malcolm is a member of the Free Software Foundation Europe and ASTP, associate professor of law at the University of Barcelona, ¿¿mentor in Tecniospring Industry and other programs for entrepreneurs and frequent speaker at conferences and seminars in the field of ICTs and entrepreneurship in the digital world.
INNOVATION MINDSET ACADEMY (IMA) 2022
The 1st edition of the Innovation Mindset Academy (IMA), a new training initiative put together by TBDO, CRG ISA and Training, took place in March 2022 within the framework of the European Training Network Chromdesign, coordinated by CRG's Group Leader Luciano Di Croce.
The IMA scheme was ideated to be highly interactive and activity-based to take PhD students through an entrepreneurial immersion experience while instilling an entrepreneurial mindset, helping students to develop their skills to convert lab-ideas into business ones.
IMA participants worked on their own business ideas for a week while engaging in discussions with entrepreneurs and scientists in business. The topics covered were intellectual property protection and disclosure, value creation, and demanded skill sets from researchers in a business environment.
The IMA 2022 stands as the optimal prelude of the next CRG BioBussines School Edition, to take place in 2023.
TBDO Sessions Tony Kouzarides
28/02/202214:30OnlineTBDO SessionsTony KouzaridesSenior Group Leader, Gurdon Institute and Director/Co-founder of the Milner Therapeutics Institute"Lessons from a career in academia and business”Host: Sanz Molinero, Ana IsabelAbstract:Short Bio
Tony Kouzarides is professor of Cancer Biology at the University of Cambridge. He is a Senior Group Leader at the Gurdon Institute and director/co-founder of the Milner Therapeutics Institute. Tony did his PhD at the University of Cambridge and postdoctoral work at MRC Laboratory of Molecular Biology and at New York University Medical Center. His research group at the Gurdon Institute is focused on epigenetic modifications and their involvement in cancer. Tony is co-founder of Abcam plc, a research reagents supplier, based on the Cambridge Biomedical Campus, STORM Therapeutics, a drug discovery company based in on the Cambridge Babraham Campus, and Chroma Therapeutics, based in Oxford. He is the founder and director of Cambridge Gravity, an organization that supports Cambridge Science and the founder of a cancer charity in Spain (Vencer el Cancer). Tony is a Fellow of the Royal Society (FRS), a Fellow of the British Academy of Medical Sciences (FMedSci), a fellow of the American Academy of Arts and sciences (AAAS), a fellow of the Cyprus Academy of Science and a member of the European Molecular Biology organization. He has been awarded the Wellcome Trust Award for Research in Biochemistry Related to Medicine, the Tenovus Medal, the Bodossaki Foundation prize in Biology, the Bijvoet Medal, the Biochemical Society Award, the Novartis Medal and Prize, the Heinrich Wieland Prize, the Nemitsas Prize and the Cyprus Science Excellence award. Watch the seminar recording here: https://youtu.be/ehrfJBRYjyg
Two CRG projects have been awarded ERC Proof of Concept grants
IMPACCT and MycoVAP projects both will receive ERC PoC grants to explore potential clinical applications of their recent results on breast cancer and pneumonia respectively.
Microomics awarded the “Impulso” Prize
The CRG spin off Microomics has been awarded the “Impulso” Prize.
BIST funds five multidisciplinary research projects through the 2017 Ignite awards
CRG will participate in the Phase-Chrom project, led by CRG researcher Catalina Romero and Juan Andrés Torreno at ICFO.
CRG and Eugin sign a collaboration agreement on molecular research applied to assisted reproduction
The project entails collaboration of four working groups that will focus their research on gaining insights into the aging of ovules, their sensitivity to the passage of time, and studying whether...